Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 5/20 | 0.49 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.48 |
| ▸ | HTR1D | P28221 | 2/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | EGFR | P00533 | 6/20 | 0.38 |
| ▸ | IGF1R | P08069 | 6/20 | 0.38 |
| ▸ | FLT4 | P35916 | 6/20 | 0.38 |
| ▸ | KDR | P35968 | 6/20 | 0.38 |
| ▸ | SPR | P35270 | 1/20 | 0.34 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.33 |
| ▸ | HTR1A | P08908 | 1/20 | 0.33 |
| ▸ | HTR1B | P28222 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25100768 | 0.81 | HTR6 (0.47) | HTR6ADRB2HTR1DHTR2AEGFR | |
| SCHEMBL10716608 | 0.80 | POLB (0.46) | HTR6ADRB2HTR1DHTR2AHASPIN | |
| SCHEMBL10494794 | 0.80 | HTR6 (0.42) | HTR6ADRB2HTR1DHTR2A | |
| SCHEMBL7749047 | 0.74 | HTR2A (0.68) | HTR6HTR2A | |
| SCHEMBL28309971 | 0.69 | ADRB2 (0.67) | HTR6ADRB2HTR1DHTR2AEGFR | |
| SCHEMBL6664111 | 0.67 | HTR2A (0.56) | HTR6ADRB2HTR2A | |
| SCHEMBL4460363 | 0.66 | TAAR1 (0.47) | — | |
| SCHEMBL25951463 | 0.66 | HTR6 (0.41) | HTR6 | |
| SCHEMBL10695378 | 0.66 | HTR6 (0.58) | HTR6HTR1DHTR1AHTR1B | |
| SCHEMBL1130016 | 0.65 | ADRB2 (1.00) | HTR6ADRB2HTR1DHTR2AHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023177294-A1 | TRANSMUCOSAL DELIVERY OF PSYCHOACTIVE COMPOUNDS | PLETHORA THERAPEUTICS B.V. (NL) | 2023-09-21 | — | — | WO | claimed |
| WO-2023177294-A1 | TRANSMUCOSAL DELIVERY OF PSYCHOACTIVE COMPOUNDS | PLETHORA THERAPEUTICS B.V. (NL) | 2023-09-21 | — | — | WO | disclosed |